NCT06843967 2026-03-13A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Recruiting54 enrolled
NCT04794127 2026-02-18TRABEPIOMario Negri Institute for Pharmacological ResearchPhase 2 Completed10 enrolled